The peptide problem: Hype is outrunning the evidence Gray Market Peptides: So Much Hype, So Little Data The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps